Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Prevalence rates of overweight and obesity and their associations with cardiometabolic and renal factors. SIMETAP-OB study
Antonio Ruiz-García; Ezequiel Arranz-Martínez; Luis Enrique Morales-Cobos; Juan Carlos García-Álvarez; Nerea Iturmendi-Martínez; Montserrat Rivera-Teijido;
Clin Investig Arterioscler. 2022;34:291-302
Multizonal observational study conducted by clinical practitioners on Repatha® use in patients with hyperlipidemia (ZERBINI): Colombian results
Heidy M. Roncancio; Julián R. Lugo-Peña; Ángel A. García; Janeth Leal; Carlos A. Hoyos; Johnny A. Beltrán; César L. Cruz; Carol Paez-Cano; Mariana Pineda-Posada; Eduardo Contreras;
Clin Investig Arterioscler. 2024;36:22-32
Analysis of the evolocumab (Repatha®) patient support program for patients with cardiovascular disease in Colombia
Ángel Alberto García-Peña; Mariana Pineda-Posada; Carol Páez-Canro; César Cruz; Daniel Samacá-Samacá;
Clin Investig Arterioscler. 2023;35:280-9